BridgeBio Pharma, Inc. Common Stock, Value, Issued
BridgeBio Pharma, Inc. (BBIO) had Common Stock, Value, Issued of $206.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-10
- 2026-06-30: Common Stock, Value, Issued $206.00K.
- 2026-03-31: Common Stock, Value, Issued $204.00K.
- 2025-12-31: Common Stock, Value, Issued $202.00K.
- 2025-09-30: Common Stock, Value, Issued $200.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $206.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $204.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $202.00K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $198.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $197.00K 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $196.00K 10-K · filed 2026-02-24 | |
| 2024-09-30 | $195.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $194.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $193.00K 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $181.00K 10-K · filed 2025-02-20 | |
| 2023-09-30 | $180.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $168.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $167.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $157.00K 10-K · filed 2024-02-22 | |
| 2022-09-30 | $156.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $154.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $154.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $154.00K 10-K · filed 2023-02-23 | |
| 2021-09-30 | $153.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $153.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $152.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $125.00K 10-K · filed 2022-02-25 | |
| 2020-09-30 | $125.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $125.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $124.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $124.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $117.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $92.00K 10-Q · filed 2020-08-11 | $0.00 10-Q · filed 2019-08-14 |
| 2019-05-17 | $0.00 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $92.00K 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $92.00K 10-K · filed 2020-03-03 | |
| 2017-12-31 | $51.00K 10-K · filed 2020-03-03 | |
| 2016-12-31 | $21.00K 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |